Investment Analysts’ Recent Ratings Updates for Intuitive Surgical (ISRG)

Intuitive Surgical (NASDAQ: ISRG) recently received a number of ratings updates from brokerages and research firms:

• 5/24/2026 – Intuitive Surgical was downgraded by Wall Street Zen from “buy” to “hold”.
• 5/19/2026 – Intuitive Surgical had its “hold (c)” rating reaffirmed by Weiss Ratings.
• 5/18/2026 – Intuitive Surgical had its price target lowered by Bank of America Corporation from $650.00 to $520.00. They now have a “buy” rating on the stock.
• 5/16/2026 – Intuitive Surgical was upgraded by Wall Street Zen from “hold” to “buy”.
• 4/23/2026 – Intuitive Surgical was given a new $651.00 price target by Barclays PLC. They now have an “overweight” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by HSBC Holdings plc from $653.00 to $604.00. They now have a “buy” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target raised by Robert W. Baird from $575.00 to $610.00. They now have an “outperform” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target raised by The Goldman Sachs Group, Inc. from $609.00 to $621.00. They now have a “buy” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by Jefferies Financial Group Inc. from $560.00 to $515.00. They now have a “hold” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by Raymond James Financial, Inc. from $615.00 to $577.00. They now have an “outperform” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by Leerink Partners from $622.00 to $573.00. They now have an “outperform” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by JPMorgan Chase & Co. from $625.00 to $550.00. They now have an “overweight” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by TD Cowen from $660.00 to $585.00. They now have a “buy” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by Piper Sandler from $620.00 to $580.00. They now have an “overweight” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its “buy” rating reaffirmed by BTIG Research. They now have a $574.00 price target on the stock.
• 4/15/2026 – Intuitive Surgical had its price target lowered by Truist Financial Corporation from $650.00 to $580.00. They now have a “buy” rating on the stock.
• 4/15/2026 – Intuitive Surgical had its price target lowered by Robert W. Baird from $645.00 to $575.00. They now have an “outperform” rating on the stock.
• 4/13/2026 – Intuitive Surgical was given a new $525.00 price target by Mizuho. They now have a “neutral” rating on the stock.
• 4/10/2026 – Intuitive Surgical had its “buy” rating reaffirmed by BTIG Research. They now have a $616.00 price target on the stock.
• 4/8/2026 – Intuitive Surgical had its price target lowered by The Goldman Sachs Group, Inc. from $714.00 to $609.00. They now have a “buy” rating on the stock.
• 4/6/2026 – Intuitive Surgical had its price target lowered by Evercore Inc from $550.00 to $480.00. They now have a “neutral” rating on the stock.
• 3/30/2026 – Intuitive Surgical was downgraded by Zacks Research from “strong-buy” to “hold”.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00. Following the transaction, the executive vice president owned 6,120 shares of the company’s stock, valued at $2,735,334. This represents a 6.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Mark Brosius sold 2,362 shares of Intuitive Surgical stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the completion of the transaction, the senior vice president owned 3,554 shares in the company, valued at approximately $1,772,308.72. This trade represents a 39.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 5,701 shares of company stock worth $2,783,807. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.